BSE filing, NSE: ARMANFIN. Summary written from the filing by ALFA Finder's alert engine.
Arman Financial Services Ltd: key numbers
- Share price
- ₹1,380.80
- Market cap
- ₹1,456 Cr
- Revenue (annual)
- ₹645.9 Cr
- Net profit (annual)
- ₹56.61 Cr
- P/E (TTM)
- 12.5×Sector 19.7×
- Promoter holding
- 21.93%-0.07% QoQ
- FII holding
- 2.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arman Financial Services Ltd
All →Arman Financial Services Board Meeting Date
Arman Financial Services scheduled a board meeting for November 4, 2026 to consider unaudited quarterly and half-year results. The trading window for designated persons remains closed until 48 hours after the results are declared.
Arman Financial Services Credit Rating
CARE Ratings reaffirmed Arman Financial's 'CARE A-' rating on its NCDs and revised the outlook from Negative to Stable, covering its subsidiary Namra Finance too. The rated facilities total ₹42.00 crore plus a proposed ₹28.89 crore NCD issue.
Arman Financial Services Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ending September 30, 2026.
Arman Financial Services Management Change
Arman Financial Services Limited appointed Mr. Chandramouli Akkiraju as Chief Business Officer of its wholly owned subsidiary, Namra Finance Limited, effective October 16, 2026.
Arman Financial Services Promoter Selling
Promoter Himani Manakiwala sold 500 Arman Financial Services shares in the open market. The reduction trimmed his stake from 4,834 to 4,334 shares.
- Promoter stake change
- -0.01%
Arman Financial Services Debt & Borrowing: ₹0.22 Cr
Arman Financial Services Limited paid Rs. 0.22 Crore in monthly interest for its NCDs. The payment was completed on October 05, 2026, for ISIN INE109C07105.
- Value
- ₹0.22 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.